Investor Sues Drug Company, Others Over Clinical Test Result Misrepresentations
NEWARK, N.J. — A shareholder filed a securities class action complaint in New Jersey federal court on June 9, alleging that a pharmaceutical company and certain of its executive officers misrepresented...To view the full article, register now.
Already a subscriber? Click here to view full article